A novel role for the adipokine visfatin/pre-B cell colony-enhancing factor 1 in prostate carcinogenesis

Peptides

Volumn 31, Issue 1, 2010, Pages 51-57

  Patel, Snehal T ^a,b   Mistry, Tina ^a,b   Brown, James E P ^c   Digby, Janet E ^a   Adya, Raghu ^a   Desai, Ken M ^b   Randeva, Harpal S ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

Author keywords

MMP 2; MMP 9; PBEF; Proliferation; Prostate cancer; Visfatin

Indexed keywords

ADIPOCYTOKINE; ANDROGEN; GELATINASE A; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; METASTASIS; OBESITY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM METASTASIS; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PRECURSOR CELLS, B-LYMPHOID; PROSTATE; PROSTATIC NEOPLASMS;

EID: 72749101694     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.10.001     Document Type: Article

References (30)

1. Adya R., Tan B.K., Punn A., Chen J., and Randeva H.S. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc Res 78 (2008) 356-365
2. Bae S.K., Kim S.R., Kim J.G., Kim J.Y., Koo T.H., Jang H.O., et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett 580 (2006) 4105-4113
3. Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
4. Buschemeyer III W.C., and Freedland S.J. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 52 (2007) 331-343
5. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 (2003) 1625-1638
6. Cross T.G., Scheel-Toellner D., Henriquez N.V., Deacon E., Salmon M., and Lord J.M. Serine/threonine protein kinases and apoptosis. Exp Cell Res (2002) 34-41
7. Deo D.D., Rao A.P., Bose S.S., Ouhtit A., Baliga S.B., Rao S.A., et al. Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells. J Biomed Biotechnol 2008 (2008) 163902
8. Feldman B.J., and Feldman D. The development of androgen-independent prostate cancer. Nat Rev 1 (2001) 34-45
9. Folgueira M.A., Carraro D.M., Brentani H., Patrao D.F., Barbosa E.M., Netto M.M., et al. Gene expression profile associated with response to doxorubicin-based therapy in breast cancer. Clin Cancer Res 11 (2005) 7434-7443
10. Freedland S.J., and Platz E.A. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29 (2007) 88-97
11. Haider D.G., Schindler K., Schaller G., Prager G., Wolzt M., and Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91 (2006) 1578-1581
12. Hasmann M., and Schemainda I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63 (2003) 7436-7442
13. Huang X., Chen S., Xu L., Liu Y., Deb D.K., Platanias L.C., et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65 (2005) 3470-3478
14. Hufton S.E., Moerkerk P.T., Brandwijk R., de Bruine A.P., Arends J.W., and Hoogenboom H.R. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett 463 (1999) 77-82
15. Incorvaia L., Badalamenti G., Rini G., Arcara C., Fricano S., Sferrazza C., et al. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res 27 (2007) 1519-1525
16. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 (2004) 2548-2556
17. Kim S.R., Bae S.K., Choi K.S., Park S.Y., Jun H.O., Lee J.Y., et al. Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem Biophys Res Commun 357 (2007) 150-156
18. Kitani T., Okuno S., and Fujisawa H. Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor. FEBS Lett 544 (2003) 74-78
19. Mistry T., Digby J.E., Chen J., Desai K.M., and Randeva H.S. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun 348 (2006) 832-838
20. Mistry T., Digby J.E., Desai K.M., and Randeva H.S. Obesity and prostate cancer: a role for adipokines. Eur Urol 52 (2007) 46-53
21. Quinn M., and Babb P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I. International comparisons. BJU Int 90 (2002) 162-173
22. Ricote M., Garcia-Tunon I., Bethencourt F., Fraile B., Onsurbe P., Paniagua R., et al. The p38 transduction pathway in prostatic neoplasia. J Pathol 208 (2006) 401-407
23. Saarialho-Kere U.K., Chang E.S., Welgus H.G., and Parks W.C. Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 90 (1992) 1952-1957
24. Saikali Z., Setya H., Singh G., and Persad S. Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells. Cancer Cell Int 8 (2008) 10
25. Samal B., Sun Y., Stearns G., Xie C., Suggs S., and McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 14 (1994) 1431-1437
26. Simon M. Bush supersizes effort to weaken the World Health Organization. Int J Health Serv 35 (2005) 405-407
27. von Hafe P., Pina F., Perez A., Tavares M., and Barros H. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 12 (2004) 1930-1935
28. Wang P., Xu T.Y., Guan Y.F., Su D.F., Fan G.R., and Miao C.Y. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81 (2009) 370-380
29. Wilson S.R., Gallagher S., Warpeha K., and Hawthorne S.J. Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors. Prostate 60 (2004) 168-174
30. Xie H., Tang S.Y., Luo X.H., Huang J., Cui R.R., Yuan L.Q., et al. Insulin-like effects of visfatin on human osteoblasts. Calcif Tissue Int 80 (2007) 201-210